PAPER Ng TK, Beck T, Liu X, Desai P, Holland T, Dhana K, Krueger K, Wilson RS, Evans DA, Rajan KB

Longitudinal associations between lipid panel and cognitive decline modified by APOE 4 carrier status in biracial community-dwelling older adults: Findings from the Chicago health and aging project.

Arch Gerontol Geriatr. 2025 Mar 18;134:105825. Epub 2025 Mar 18 PubMed.

PAPER Haque A, Alenezi KM, Abdul Rasheed MS, Rahman MA, Anwar S, Ahamad S, Gupta D

Experimental and theoretical studies on structural changes in the microtubule affinity-regulating kinase 4 (MARK4) protein induced by N-hetarenes: a new class of therapeutic candidates for Alzheimer's disease.

Front Med (Lausanne). 2025;12:1529845. Epub 2025 Mar 19 PubMed.

PAPER Tonelli E, Malecka J, Barberis E, Romano C, Pessolano E, Talmon M, Genazzani AA, Casali C, Biggiogera M, Manfredi M, Tapella L, Lim D, Dematteis G

Remodelling of Cellular Protein Homeostasis by Enhanced ER-Mitochondrial Tethering.

Contact (Thousand Oaks). 2025;8:25152564251329704. Epub 2025 Apr 1 PubMed.

PAPER Sun Y, Liu Z, Zhang Z, Kang Y, Wang X, Zhang Y, Liu Y, Zhao P

Human induced pluripotent stem cell models for Alzheimer's disease research: a bibliometric analysis.

Front Hum Neurosci. 2025;19:1548701. Epub 2025 Mar 19 PubMed.

PAPER Alrouji M, Alshammari MS, Majrashi TA, Zuberi A, Shahwan M, Atiya A, Shamsi A

Unraveling human transferrin-tryptamine interactions: a computational and biophysical approach to Alzheimer's disease therapeutics.

Front Pharmacol. 2025;16:1540736. Epub 2025 Mar 19 PubMed.

PAPER Nahar L, Charoensup R, Kalieva K, Habibi E, Guo M, Wang D, Kvasnica M, Onder A, Sarker SD

Natural products in neurodegenerative diseases: recent advances and future outlook.

Front Pharmacol. 2025;16:1529194. Epub 2025 Mar 19 PubMed.

PAPER Zhou M, Tang AS, Zhang H, Xu Z, Ke AM, Su C, Huang Y, Mantyh WG, Jaffee MS, Rankin KP, DeKosky ST, Zhou J, Guo Y, Bian J, Sirota M, Wang F

Identifying progression subphenotypes of Alzheimer's disease from large-scale electronic health records with machine learning.

J Biomed Inform. 2025 Apr 1;165:104820. Epub 2025 Apr 1 PubMed.

PAPER Han J, Hong R, Cao C, Zhang L, Sun A, Li Y, Chi Y, Zhang L, Yang Y, Qu X

Suppression of KDM5C mitigates the symptoms of Alzheimer's disease by up-regulating BDNF expression.

Neurochem Int. 2025 Apr 1;186:105975. Epub 2025 Apr 1 PubMed.

PAPER Kusakari S, Suzuki H, Nawa M, Sudo K, Yamazaki R, Miyagi T, Ohara T, Matsuoka M, Kanekura K

Excessive expression of progranulin leads to neurotoxicity rather than neuroprotection.

Neurobiol Dis. 2025 Apr 1;209:106895. Epub 2025 Apr 1 PubMed.

PAPER Ullah A, Lee GJ, Park JH, Park AR, Kwon HT, Lim SI

Human serum albumin-coated cellulose beads for extracorporeal amyloid-beta scavenging: A promising Alzheimer's disease-modifying approach.

Int J Biol Macromol. 2025 Apr 1;309(Pt 2):142757. Epub 2025 Apr 1 PubMed.

Interdisciplinary Tutorial Workshop on Aging & Brain Health- 3rd

CONFERENCE 2026-01-06 00:00:00-2026-01-08 00:00:00 Aspen Snowmass, Colorado 06 &#x2013 08 January 2026 0

Roderick Moore

Graduate Student
United States

Esther Rojo

, Spain

Jennifer Lombardo

United States

PAPER Abdi Z, Yong KX, Schott JM, Gatt A, Revesz T, Crutch SJ, Lashley T

Pathological Characterisation of Posterior Cortical Atrophy in Comparison With Amnestic Alzheimer's Disease.

Neuropathol Appl Neurobiol. 2025 Apr;51(2):e70007. PubMed.